GENFIT: Publication of the 2024 Extra-Financial Performance Report (fiscal year 2023)
Lille , Cambridge , Zurich , April 25, 2024 - GENFIT , a late-stage biopharmaceutical company committed to improving the lives of patients with rare, life-threatening liver diseases, today announced...